zanamivir has been researched along with baicalein in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Cinatl, J; Michaelis, M; Schubert-Zsilavecz, M; Sithisarn, P | 1 |
2 other study(ies) available for zanamivir and baicalein
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Differential antiviral and anti-inflammatory mechanisms of the flavonoids biochanin A and baicalein in H5N1 influenza A virus-infected cells.
Topics: Anti-Inflammatory Agents; Antiviral Agents; Cells, Cultured; Cytokines; Drug Evaluation, Preclinical; Drug Synergism; Epithelial Cells; Flavanones; Flavonoids; Genistein; Humans; Influenza A Virus, H5N1 Subtype; Inhibitory Concentration 50; Macrophages; Microbial Sensitivity Tests; Signal Transduction; Viral Load; Virus Replication; Zanamivir | 2013 |